Compositions of an anticonvulsant and an antipsychotic drug for affecting weight loss

Details for Australian Patent Application No. 2005206139 (hide)

Owner Orexigen Therapeutics, Inc. Duke University

Inventors Gadde, Kishore M.; Krishnan, K. Ranga R.

Agent Cullen & Co

Pub. Number AU-B-2005206139

PCT Pub. Number WO2005/070461

Priority 60/567,896 03.05.04 US; 60/535,800 13.01.04 US; 60/535,799 13.01.04 US; 60/616,393 05.10.04 US

Filing date 11 January 2005

Wipo publication date 4 August 2005

Acceptance publication date 26 February 2009

International Classifications

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/155 (2006.01) - Amidines (), e.g. guanidine (HNC(NH)NH), isourea (HNC(OH)NH), isothiourea (HNC(SH)NH)

A61K 31/352 (2006.01) - condensed with carbocyclic rings, e.g. cannabinols, methantheline

A61K 31/42 (2006.01) - Oxazoles

A61K 31/423 (2006.01) - condensed with carbocyclic rings

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 33/00 (2006.01) Medicinal preparations containing inorganic active ingredients

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

17 August 2006 PCT application entered the National Phase

  PCT publication WO2005/070461 Priority application(s): WO2005/070461

19 April 2007 Change of Name(s) of Applicant(s), Section 104

  Duke University The name of the applicant has been changed to Gadde, Kishore; Krishnan, K. Ranga

28 June 2007 Assignment before Grant

  Gradde, Kishore M.; Krishnan, K. Ranga R. The application has been assigned to Duke University; Orexigen Therapeutics, Inc.

26 February 2009 Application Accepted

  Published as AU-B-2005206139

25 June 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005206143-Long-term delivery formulations and methods of use thereof

2005206137-Treatment of aromatase inhibitor therapy-related osteoporosis